The U.S. Supreme Court on Monday agreed to consider a Teva Pharmaceutical Industries Ltd. appeal of a ruling that invalidated a company patent on its blockbuster multiple-sclerosis drug Copaxone.
Source: http://blogs.wsj.com/law/2014/03/31/supreme-court-to-review-teva-appeal-in-copaxone-case/?mod=WSJBlog
real estate attorney
No comments:
Post a Comment